P. Srilar, “Comparison of 1 Year Recurrent Rate in High-Risk of Recurrent Non-Muscle Invasive Bladder Cancer Who Had Received Induction Course of Intravesical BCG after TUR-BT Between Combination with Immediate Intravesical Mitomycin C and Induction Course of Intrave”, Insight Urol, vol. 33, no. 1, pp. 34–42, Jun. 2012.